S-Ketamine modulates hyperalgesia in patients with chronic pancreatitis pain

Regional Anesthesia and Pain Medicine

Volumn 36, Issue 3, 2011, Pages 303-307

  Bouwense, Stefan A W ^a   Buscher, Hessel C J L ^a   Van Goor, Harry ^a   Wilder Smith, Oliver H G ^b  

^a Pain and Nociception Neuroscience Research Group   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; KETANEST S; MORPHINE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC PAIN; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; FEMALE; HUMAN; HYPERALGESIA; MALE; MCGILL PAIN QUESTIONNAIRE; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; QUANTITATIVE SENSORY TESTING; QUESTIONNAIRE; RACEMIZATION; SENSORY ANALYSIS; SINGLE BLIND PROCEDURE; TASTE DISORDER; VISUAL ANALOG SCALE;

CROSS-OVER STUDIES; FEMALE; HUMANS; HYPERALGESIA; INFUSIONS, INTRAVENOUS; KETAMINE; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PANCREATITIS, CHRONIC; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOISOMERISM;

EID: 79955622326     PISSN: 10987339     EISSN: None     Source Type: Journal    
DOI: 10.1097/AAP.0b013e3182177022     Document Type: Article

References (24)

1. Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Engl J Med. 1995;332:1482-1490.
2. Andren-Sandberg A, Hoem D, Gislason H. Pain management in chronic pancreatitis. Eur J Gastroenterol Hepatol. 2002;14:957-970.
3. van Esch AA, Wilder-Smith OH, Jansen JB, van Goor H, Drenth JP. Pharmacological management of pain in chronic pancreatitis. Dig Liver Dis. 2006;38:518-526. (Pubitemid 44356227)
4. Ceyhan GO, Demir IE, Rauch U, et al. Pancreatic neuropathy results in "neural remodeling" and altered pancreatic innervation in chronic pancreatitis and pancreatic cancer. Am J Gastroenterol. 2009;104:2555-2565.
5. Buscher HC, Wilder-Smith OH, van Goor H. Chronic pancreatitis patients show hyperalgesia of central origin: a pilot study. Eur J Pain (London, England). 2006;10:363-370.
6. Drewes AM, Gratkowski M, Sami SA, Dimcevski G, Funch-Jensen P, Arendt-Nielsen L. Is the pain in chronic pancreatitis of neuropathic origin? Support from EEG studies during experimental pain. World J Gastroenterol. 2008;14:4020-4027.
7. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 1993;52:259-285. (Pubitemid 23080546)
8. Simonnet G. Opioids: from analgesia to anti-hyperalgesia? Pain. 2005;118:8-9. (Pubitemid 41566579)
9. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science (New York, NY). 2000;288:1765-1769.
10. Adams HA. Mechanisms of action of ketamine. Anaesthesiol Reanim. 1998;23:60-63.
11. Subramaniam K, Subramaniam B, Steinbrook RA. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg. 2004;99:482-495. (Pubitemid 38970424)
12. Drewes AM, Krarup AL, Detlefsen S, Malmstrom ML, Dimcevski G, Funch-Jensen P. Pain in chronic pancreatitis: the role of neuropathic pain mechanisms. Gut. 2008;57:1616-1627.
13. O'Neill S, Manniche C, Graven-Nielsen T, Arendt-Nielsen L. Generalized deep-tissue hyperalgesia in patients with chronic low-back pain. Eur J Pain (London, England). 2007;11:415-420. (Pubitemid 46366764)
14. Apkarian AV, Baliki MN, Geha PY. Towards a theory of chronic pain. Prog Neurobiol. 2009;87:81-97.
15. Cervero F. Visceral pain-central sensitisation. Gut. 2000;47(suppl 4): iv56-iv57; discussion iv8.
16. Buscher HC, van Goor H, Wilder-Smith OH. Effect of thoracoscopic splanchnic denervation on pain processing in chronic pancreatitis patients. Eur J Pain (London, England). 2007;11:437-443. (Pubitemid 46366765)
17. Bell RF, Dahl JB, Moore RA, Kalso E. Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev (Online). 2006;CD004603.
18. Hocking G, Cousins MJ. Ketamine in chronic pain management: an evidence-based review. Anesth Analg. 2003;97:1730-1739. (Pubitemid 37475130)
19. Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med (Malden, Mass). 2004;5:263-275. (Pubitemid 39369246)
20. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA. NMDA antagonist neurotoxicity: mechanism and prevention. Science (New York, NY). 1991;254:1515-1518. (Pubitemid 21917493)
21. Kiefer RT, Rohr P, Ploppa A, et al. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. Pain Med (Malden, Mass). 2008;9:1173-1201.
22. Kronenberg RH. Ketamine as an analgesic: parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration. J Pain Palliat Care Pharmacother. 2002;16:27-35. (Pubitemid 35415828)
23. Blonk MI, Koder BG, van den Bemt PM, Huygen FJ. Use of oral ketamine in chronic pain management: a review. Eur J Pain (London, England). 2010;14:466-472.
24. Wilder-Smith OH. Changes in sensory processing after surgical nociception. Curr Rev Pain. 2000;4:234-241.